We have shown that administering rhGH to female adolescents in physiologic doses is able to stabilize IGF-1 in obesity, a state characterized by relative GH insufficiency, without adversely affecting glucose tolerance. Here, GH1 is linked to obesity due to melanocortin 4 receptor deficiency.